Healthcare
An Update on My Top Small-Cap Pick and What It Means for the Overall Market
The good news is that the corrective action is advancing and opportunities are developing.
Moderna's Chart Messages Are Frustrating the Bulls
The technical indicators suggest that traders should wait until a bottom pattern plays out in the shares of the vaccine maker.
This Biotech Stock Pick Is Just Starting to Make Beautiful Music
Things have started to turn up for this midcap name. Look for these shares to end the year on an up note.
UnitedHealth Shares Are Not Looking All That Healthy
Let's take the temperature of this important Dow component.
Moderna: Is It Time to Take a Shot?
Let's review the trends, charts and indicators.
For Potential Alkermes Buyers, There's a Key Price Level to Watch
The key question now is whether the biopharmaceutical stock can break out to the upside.
Align Technology Has Broken Its Bullish Alignment
Should investors still sink their teeth into this one?
Medtronic Could Weaken in the Months Ahead: New Lows Possible
Shares of the medical device company could retest the lows of December and March.
Here's My Rx for CVS After an Analyst's Positive View
Let's see what the charts of the pharmacy and health services provider suggest.
Kenvue, the J&J Healthcare Spinoff, Has Disappointed Investors
The company went public in May. Let's see what the charts tell us.
No Place to Hide? I'm Asking Questions About Two Defensive Sectors
Why are the healthcare and utilities ETFs not going up now? Let's take a deep dive.
Centene Continues to Look and Trade Weak
I didn't like it then and I don't like it now.
AbbVie's Quant Upgrade Gets My Attention. Bullish Charts Keep It
With two approaches on the same page, here's how we'd trade this drugmaker's stock.
I've Got a Play for LifeMD as It Gets Its Life Together
LifeMD had one of the best quarters among my small cap holdings this earnings season -- let's see how to trade the telehealth name.
Zoetis' Shares May Struggle to Continue Their Rally
The advance is looking mature and a shift in strategy may be called for.
As Novo Nordisk Surges on Ozempic, Wegovy, Is the Stock Looking a Little Heavy?
Unbelievably, there may be more interest in weight loss than AI right now.
Viatris Has Been Bearish for One Reason — But Is Still an Intriguing Value Play
One earnings story that caught my eye was this pharmaceutical name.
This Is Not a Drill: Get Ready for Another Big Down Leg in the Stock Market
Traders and investors should take appropriation action.
Eli Lilly Soars as Mounjaro, Growth Products Take Off: We're Upping Our Target
Here's how traders can play the stock.
Moderna Weakens With No Bottom in Sight
The stock slumped to a new 52-week low Monday.
Why Income Investors Should Consider the Big 3 Healthcare REITs
These major high-yield real estate investment trusts deserve a closer look.
Getting Another Shot of Biotech Dynavax Technologies
This vaccine developer just released strong earnings and here's how I'm using an options play to add to the name.
Here's How to Trade CVS After Earnings
Let's first check the charts and indicators.
AbbVie Rallies on an Earnings Beat: What Traders Need to Know
Buyers of the biopharmaceutical's shares are being more aggressive.
GE Is a Dumpster Fire No More: Here's How to Trade It Now
Performance is improving across the firm. The balance sheet and free cash flow are in places we never expected to see a few years ago.
Johnson & Johnson: After an Earnings Beat, Here's What to Expect From the Stock
Can the shares overcome a key price area?
UnitedHealth Jumps, But It May Not Be Out of the Woods
Has the key Dow component made a low? Is it a buy? Let's dive in.
3 Healthcare Stocks for Long-Term Dividend Growth
Let's look at three iconic names in the healthcare sector that offer solid yields.
This Summer Might Not Be As Slow as I Thought
While we may start the first half of the week without much action, prepare for an interesting next few weeks during an ordinarily quiet season.
Quest Diagnostics Is Ready to Test Higher Highs
Let's examine the charts to see what traders can do now.